Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- A programmatic approach
- Where are we now?
- Onchocerciasis: the world wide situation
- Targets in onchocerciasis control
- Eliminating a public health problem
- APOC and OCP: success in control
- Onchocerciasis in Africa
- ESPEN
- Endemicity status of onchocerciasis in WHO African region (2017)
- MDA rounds conducted against onchocerciasis in WHO African region (2013-2016)
- Onchocerciasis endemicity at community level based on nodule palpation (NP): Mapping surveys
- Onchocerciasis endemicity at community level based on skin biopsy (SB): Impact assessments
- The Americas in 1993
- The Americas in 2018
- Yemen
- Where do we want to be?
- What are realistic milestones
- Africa: APOC detailed projections
- The Americas: Elimination of the last (Yanomami) focus
- The Yanomami problem
- Yemen: National plan
- What do we need to get there?
- Monitoring and evaluation
- Understanding elimination dynamics
- Progress towards elimination in evaluated projects (1)
- Progress towards elimination in evaluated projects (2)
- National ownership
- National programmes
- Elimination mapping
- Onchocerciasis elimination mapping
- Results of delineation mapping of 'hypo-endemic' areas in 2013-2015
- No. of MDA rounds with ivermectin implemented since the inception of interventions until 2016
- Coordination with other NTD programmes
- Coordination with LF programmes
- Loiasis: Different strategy to LF programme: RAPLOA results
- Loa encephalopathy
- Development of human resources
- Human resources
- HR: a priority for APOC
- Infrastructure development
- Infrastructure
- Entomological evaluations
- Other entomological activities
- Alternative strategies
- Basic strategy
- CDTI in action
- Alternative strategies
- Test and (not) treat
- Advocacy
- The latest advocacy document
- Funding (1)
- Funding (2)
- Acknowledgements
Topics Covered
- Onchocerciasis control and the elimination of transmission
- A programmatic approach
- Where are we, where do we want to be, and how do we get there
- Understanding the Criteria for elimination
- National ownership
- Elimination mapping
- Coordination with other NTD programmes
- Development of Human Resources and Infrastructure development
- Alternative strategies
- Advocacy and Funding
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Hopkins, MBE, A. (2020, January 30). Onchocerciasis (River Blindness) 2: control and elimination [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 5, 2024, from https://doi.org/10.69645/XGZT1025.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Adrian Hopkins, MBE has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Onchocerciasis (River Blindness) 2: control and elimination
Published on January 30, 2020
54 min
HSTalks is pleased to grant unrestricted complimentary access to all lectures in the series Neglected Tropical Diseases. Persons not at a subscribing institution should sign up for a personal account.
Other Talks in the Series: Neglected Tropical Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, this is Adrian Hopkins,
we are going to go into the second talk
around onchocerciasis or river blindness.
In the first part we talked about
the actual disease, the vector,
the parasites and how we could
treat it on an individual basis,
and looked forward a little to the fact
that we could do mass treatment.
Now we are going to move into various
ways of controlling the disease in
the community, with the possibility of
an eventual elimination of the disease.
Certainly in some foci it's very
close to that in America, and
there are some areas in Africa where
we've already had some good success.
0:40
The way I thought we would do this would
be to look at it from a programme point of
view and
ask three main questions: firstly,
where are we now with our programs?
Some of these programmes
have been going for years.
Secondly, where do we want to be?
We had hoped to be stopping treatment
everywhere by 2025, that may happen,
though it probably won't in
the Democratic Republic of Congo,
South Sudan or in Angola,
not because Angola is difficult but
because it hasn't got its act together
with its treatment strategies yet.
Possibly not in the Central African
Republic where we had a good programme but
constant conflict has been a problem,
and in Yemen it's the same,
we've had some good planning but
the civil war has led to major problems.
But we do hope that we will eliminate the
transmission of the disease in most areas
and we are already
celebrating some success,
in the Americas four countries have
been declared free of the disease.
We want to start doing that in Africa, and
we should have started in Africa in 2018,
I left 2018 on the slide but
actually nothing has been done, so
we hope to celebrate in 2019,
that's where we want to be.
Then we have to look at a few principles
to answer the third question about
how to get there, how do we reach
the end game and what do we need to do?
We'll look at that under some of
the headings that you see on this slide.